Red Violet's FY 2025 Growth Highlights Execution Amidst Valuation Concerns

What happened

Red Violet reported 20% year-over-year revenue growth to $90.3 million in FY 2025, driven by organic expansion without acquisitions. A Seeking Alpha article reiterates a BUY rating, citing strong management credibility and consistent quarterly performance. However, the DeepValue master report maintains a WAIT rating, noting RDVT's current valuation already prices in sustained high growth and premium margins. Key risks include contractual revenue mix potentially slipping below 70% and a lack of disclosed public-sector wins from the Carahsoft GSA channel. Investors should await upcoming quarterly results to validate profitability, revenue quality, and growth durability before making new investment decisions.

Implication

RDVT's high valuation multiples, with a P/E of 51.1 and EV/EBITDA of 30.2, offer no margin of safety if growth quality deteriorates. The bullish narrative depends on FOREWARN user growth offsetting housing weakness in IDI's real-estate vertical, which remains a cyclical risk. Public-sector traction via Carahsoft lacks concrete wins, threatening a key growth pillar and delaying de-cyclical revenue diversification. Contractual revenue mix holding near 75% is critical to prevent increased volatility from transactional exposure. A better risk-adjusted entry may emerge around the $38 attractive level or after quarterly results show ≥20% YoY growth and ≥35% adj. EBITDA margins.

Thesis delta

The new article reinforces Red Violet's operational strength but does not alter the core investment thesis from the DeepValue report. The thesis remains that RDVT is fully valued, requiring validation of key metrics like contractual mix and public-sector wins to justify premium pricing. No shift from the WAIT rating is warranted based on this update.